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Abstract 1 
Background 2 
Epigenetic variation in the serotonin transporter gene (SLC6A4) has been shown to modulate 3 
the functioning of brain circuitry associated with the salience network (SN) and thereby may 4 
heighten the risk for mental illness. This study is the first to test this epigenetic-brain-behavior 5 
pathway in patients with anorexia nervosa (AN).  6 
Methods 7 
Resting state functional connectivity (rsFC) data and blood samples were obtained from 55 8 
acutely underweight female AN patients and 55 age-matched female healthy controls (HC). 9 
Imaging data was decomposed using independent component analysis. Bisulfite 10 
pyrosequencing was employed to analyse blood DNA methylation within the promoter region 11 
of SLC6A4. SN rsFC patterns of the group × methylation interaction were interrogated. 12 
Results  13 
We identified a positive relationship between SLC6A4 methylation levels and rsFC between 14 
the dorsolateral prefrontal cortex and the SN in AN participants relative to HC. Increased SN 15 
rsFC was found to mediate the link between SLC6A4 methylation and eating disorder 16 
symptoms in AN. Findings of methylation-related rsFC alterations were confirmed for CpG-17 
specific methylation at a locus with evidence of correspondence of methylation between brain 18 
and blood tissue.  19 
Limitations 20 
This study is cross-sectional in nature, the sample size is modest for the method and 21 
methylation levels were measured in peripheral tissue and cannot be generalized to brain 22 
tissue.  23 
Conclusion 24 
This study sheds light on the neuro-biological process of how epigenetic variation in the 25 
SLC6A4 gene may relate to rsFC in the SN that is linked to psychopathology in AN. 26 
27 
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Introduction 1 
The serotonin system has been associated with mood regulation, anxiety and the modulation 2 
of appetite1, all aspects which nominate this neurotransmitter system as a potentialcandidate 3 
involved in the pathogenesis of anorexia nervosa (AN)2. AN is characterized by severe food 4 
restriction and affective symptoms, such as depressed mood and difficulties in emotion 5 
regulation3, as well as a heightened prevalence of anxious and  obsessive personality traits4. 6 
A number of studies suggest a reduced serotonergic tone during the acute undernourished 7 
state of the disorder, e.g. the serotonin metabolite 5-hydroxyindolacetic acid (5-HIAA) in 8 
cerebrospinal fluid5 was found to be decreased, plasma prolactin response to serotonin 9 
agonists6 were blunted and whole blood serotonin content as well as tryptophan levels7 were 10 
reduced. In the weight-recovered state however, former AN participants may exhibit 11 
hyperserotonergic dysfunction8. The assumption of increased serotonin transmission being a 12 
trait-marker of the disorder is supported by decreased platelet MAO-B activity9 and altered 13 
cerebral 5-HT1A and 5-HT2A receptor binding10,11. It has been hypothesized that serotonergic 14 
dysfunctions may drive body image distortions and self-starvation in AN12.  15 
However, associations between genetic polymorphisms of the serotonergic system, in 16 
particular the serotonin transporter SLC6A4, and AN could not be replicated13. Therefore an 17 
interest in the epigenome has gained momentum. Epigenetic processes such as DNA 18 
methylation may mediate environmental effects on gene expression without changing the DNA 19 
sequence. During DNA methylation, a methyl group is added to a cytosine residue, often 20 
adjacent to a guanine nucleotide. These so-called CpG-sites tend to cluster together in CpG-21 
islands. In the promoter region of genes, CpG-islands are often demethylated, whereas the 22 
methylated state is commonly associated with reduced gene expression14. DNA methylation 23 
within the SLC6A4 promotor region appears to be of functional relevance as it has been found 24 
to predict lower SLC6A4 mRNA expression15. Furthermore, we have previously reported that 25 
DNA methylation at CpG site 13 (cg14692377) significantly correlates between blood and brain 26 
tissue obtained simultaneously from paired blood and temporal lobe biopsy samples16. This 27 
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CpG was also shown to correlate in paired pre-mortem blood and post-mortem brain samples. 1 
While SLC6A4 methylation has been reported to play a role in depressive disorders and 2 
schizophrenia17, the only existing candidate-gene study in AN found no group differences in 3 
comparison to healthy controls (HC)18. A study using a methylome-wide approach also did not 4 
provide support for a link between SLC6A4 DNA methylation and a diagnosis of AN19. 5 
However, related phenotypes such as cortisol stress reactivity have been repeatedly 6 
associated with altered SLC6A4 methylation20. Expanding the scope by integrating epigenetic 7 
and neuroimaging data may allow us to test the complex interplay between genes, brain 8 
function and eating-disorder related abnormal  behavior21,22.  9 
One promising neuroimaging technique is resting state functional connectivity (rsFC), which is 10 
defined as temporally correlated low frequency blood oxygen level-dependent (BOLD) signal 11 
fluctuation of distinct brain regions while the participant is at rest. This method is sensitive to 12 
changes in “communication” between spatially separated brain regions and hence has been 13 
argued to be more sensitive to the effects of genetic and environmental variation in 14 
heterogeneous phenotypes such as psychiatric disorders23,24. 15 
Recent evidence from rsFC studies points to a dysfunction in the salience network (SN) as a 16 
prominent feature of several mental disorders23 including AN. The SN, comprised of the dorsal 17 
anterior cingulate cortex, the insular cortices and additional limbic structures such as the 18 
amygdala23, is associated with detecting, filtering and integrating biologically relevant sources 19 
of salience such as emotional information, homeostatic regulation and reward value25. While 20 
some studies demonstrated aberrant functional within- and between network connectivity of 21 
the SN in AN, others found only indirect evidence for SN abnormalities in patients in the acutely 22 
underweight state26,27. Importantly, studies in healthy participants have observed that activity 23 
in key nodes of the SN including the amygdala28 and insula29 as well as amygdala 24 
connectivity30 might depend on SLC6A4 methylation. Using a monozygotic twin-design, a 25 
recent study demonstrated an association between SLC6A4 methylation and brain responses 26 
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to negative stimuli in frontal-limbic regions overlapping the SN, that was independent of DNA 1 
sequence variations31. 2 
Based on the fact that previous studies in AN identified neural alterations in the SN, which has 3 
also been identified as neural correlate of SLC6A4 methylation, we assume that a serotonin-4 
related epigenetic-brain-behavior pathway (discussed in detail in Palma-Gaudiel & Fananas17) 5 
may also be highly relevant for AN. The authors describe a neuro-biological pathway that is 6 
rooted in a SLC6A4 methylation mediated reduction of serotonin transporter expression. This 7 
reduction may lead to changes in the serotonergic tone, associated with altered reactivity and 8 
connectivity of SN-relevant brain regions and mental health problems. 9 
Thus, in light of this proposed epigenetic-brain-behavior pathway for AN, the aim of this study 10 
is to examine the association between SLC6A4 methylation, SN rsFC and eating disorder (ED) 11 
symptoms in acutely ill AN patients compared to matched HC.  12 
Methods and materials 13 
Participants 14 
The sample of the current study consisted of a total of 110 female volunteers: 55 acute AN 15 
participants according to DSM-5 (AN patients; 12-28 years old) and 55 pair-wise age matched 16 
female HC (12-28 years old). All AN patients were assessed within 96 hours after the beginning 17 
of a behaviorally-oriented nutritional rehabilitation program. Within the AN group, 53 of the 18 
patients were of the restrictive and two of the binge/purging subtype; seven had comorbid 19 
psychiatric disorders (four patients with depressive disorders including dysthymia, three with 20 
anxiety disorder and one with obsessive compulsive disorder). Six patients and 10 HC reported 21 
to smoke cigarettes currently or have been smoking in the past.  22 
We applied several exclusion criteria for each group (see Supplemental Materials (SM) 1.1) – 23 
most importantly psychotropic medication other than selective serotonin reuptake inhibitors 24 
(SSRI) within four weeks prior to the study (n=1), binge eating, or diagnosis of bulimia nervosa, 25 
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substance abuse, neurologic or medical conditions. This study was approved by the Review 1 
Board of the TU Dresden and all participants (and if underage their guardians) gave written 2 
informed consent. 3 
Clinical measures 4 
To ascertain the absence or presence of a current ED, the expert form of the Structured 5 
Interview for Anorexia and Bulimia Nervosa for DSM-IV (SIAB-EX32) was conducted with all 6 
participants. Interviews were adapted to DSM-5 criteria (no amenorrhea criteria) and carried 7 
out by clinically experienced and trained research assistants under the supervision of the 8 
attending child and adolescent psychiatrist. IQ was estimated with a short version of the 9 
German adaption of the Wechsler Adult Intelligence Scale33  or a short version of the German 10 
adaption of the Wechsler Intelligence Scale for Children34  for participants aged 15 years or 11 
younger.  12 
ED-specific psychopathology was assessed using the short version of the Eating Disorders 13 
Inventory (EDI-2)35. Depressive symptoms were examined using the German version of the 14 
Beck Depression Inventory (BDI II)36. Symptoms of anxiety were determined using the anxiety 15 
subscale of the Symptom Checklist 90 Revised (SCL-90-R)37. 16 
 17 
 18 
Blood DNA methylation sample processing and quality control 19 
Quantitative peripheral DNA methylation at 15 CpG sites within the promoter-associated CpG 20 
island of SLC6A4 initially described by Philibert et al.38 was performed by Varionostic GmbH 21 
(Ulm, Germany, http://www.varionostic.de). We focussed on 15 CpG sites within the amplicon 22 
3 of a 799-bp region (originally CpG 43-57, referred to in the current study as CpG 1-15), as a 23 
prior study observed significant interindividual variation regarding methylation within this (but 24 
not in other) sub-region as well as a significant correlation with SN rsFC30. DNA methylation 25 
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within this sub-region has also been shown to correlate between blood and brain tissue16. 1 
Moreover, previous studies have argued that CpG-specific methylation rather than average 2 
methylation corresponds with mRNA expression15,39. To further investigate the correlation 3 
between peripheral, blood-based measures of SLC6A4 DNA methylation with those in post-4 
mortem brain tissue, we queried BECon, an online database on cross-tissue DNA 5 
methylation40. Based on whole blood and post-mortem brain tissue from three regions (frontal, 6 
temporal and parietal) obtained from 16 individuals, cg14692377 showed moderate rank 7 
correlations between tissues (rhoBA10 = 0.29 (frontal), rhoBA20 = 0.36 (temporal), rhoBA10 = 0.48 8 
(parietal), indicating that in this specific case peripheral DNA methylation might indeed index 9 
brain-based methylation patterns. For analysis, genomic DNA was extracted from EDTA whole 10 
blood samples and bisulfite-treated using the EZ DNA Methylation Gold Kit (Zymo Research, 11 
Orange, CA). Subsequent pyrosequencing was performed on the Q24/ID System and percent 12 
DNA methylation at each CpG site was quantified using the PyroMark Q24 software (Qiagen). 13 
For a detailed protocol containing amplicon, sequencing as well as cross-CpG correlation and 14 
transcription factor binding site within the region, see SM 1.2. Pyrograms were visually 15 
inspected to individually verify DNA methylation estimates if they were at least three standard 16 
deviations away from the mean or if internal quality scores indicating a deviation from the 17 
expected pattern. Based on these criteria, we excluded data from one CpG (CpG 15). Mean 18 
missingness after exclusion was 0.58% across CpGs [range: 0 - 1.82%] and participants 19 
[range: 0 - 35.71%]. Missing values were subsequently imputed using predictive mean 20 
matching with default settings as implemented in the R mice package.   21 
MRI-data acquisition and preprocessing 22 
Data was acquired with a 3T Siemens Trio. The T1-weighted structural brain scans were 23 
acquired with a rapid acquisition gradient echo (MP-RAGE) sequence with the parameters as 24 
described in SM 1.3. An 8-minute resting fMRI scan was acquired by using a gradient-echo 25 
T2*-weighted echo planar imaging (EPI) using standard parameters (see SM 1.3). During 26 
fMRI, participants were instructed to lie still with closed eyes and without falling asleep. 27 
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Functional and structural images were processed using SPM8 1 
(http://www.fil.ion.ucl.ac.uk/spm/) within the Nipype framework 2 
(http://nipy.sourceforge.net/nipype,) following standard procedures (SM 1.4).  3 
We evaluated the quality of the fMRI data by manual inspection and using artifact detection 4 
tools (ART; SM 1.4).  5 
Independent component analysis and identification of component of interest  6 
To extract temporally coherent networks, that reflect well-defined circumscribed functional 7 
properties, a spatial group independent component analysis (ICA)41 for all participants using 8 
the Group ICA fMRI Toolbox (GIFT) implemented in Matlab 9 
(http://mialab.mrn.org/software/gift) was conducted. Unlike seed-based approaches, this 10 
technique allows for an identification of a resting state network that is independent of 11 
neuroanatomical variability. After initial data reduction using principle component analysis, the 12 
fMRI data was decomposed into 24 maximally independent components by applying the 13 
infomax algorithm (SM 1.5). For each subject, component spatial maps were back-14 
reconstructed using GICA and converted to z-values. As in our previous reports42,43 15 
components of interest were identified by spatial correlation with the relevant templates 16 
(salience, fronto-parietal and visual network) by Yeo et al.44 Independent component number 17 
9 (IC9) and number 13 (IC13) mapped onto the SN template defined by Yeo et al.44 (SM 1.6).  18 
Statistical models 19 
We averaged DNA methylation levels across the 14 individual CpG sites after quality control 20 
and imputation to calculate a mean SLC6A4 methylation score (methylationmean) for each 21 
participant30. While SLC6A4 methylationmean was our main measure of interest, we also 22 
investigated effects of CpG site 13 (methylationCpG13), as there is evidence for small to 23 
moderate blood-brain correspondence of methylationCpG1316. To identify the effects of 24 
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potentially confounding variables on DNA methylation we investigated associations with age 1 
(using Pearson’s r).  2 
 3 
Regarding rsFC, spatial maps of the components of each subject were entered into SPM8 to 4 
conduct the following analyses. First, to test for basic group differences, a two-sample t-test 5 
was performed for the two components identified as SN (step 1)44. Second, the main model 6 
was examined in components for which we had found a basic group difference at step 1. 7 
Second, rsFC in components which showed group difference in step 1 were regressed on 8 
group, SLC6A4 methylationmean, their interaction and age as a covariate, with the interaction 9 
term being our main effect of interest (step 2). Third, based on previous findings as outlined 10 
above15,16 we reran the main model described in step 2 using methylationCpG13 instead of mean 11 
methylation level (step 3). Fourth, to investigate the specificity of the impact of DNA methylation 12 
on the rsFC of the SN, the group × methylationmean interaction was examined in a control 13 
analysis for the visual network (also identified by spatial correlation with a template44), a brain 14 
network which is thought to be somewhat less influenced by the serotonergic system45 (step 15 
4). Results of all models were masked using the aforementioned RSN templates and had to 16 
exceed p<0.05 family-wise error (FWE) to guard against type I errors. To test whether our main 17 
analysis (step 2) was influenced by cigarette consumption, we ran additional subanalyses 18 
excluding participants who reported to smoke currently or had been smoking in the past (AN=6; 19 
HC=10; also including occasional smoking) or were taking SSRIs (AN=1).  20 
To develop a better understanding of the group × methylationmean interaction, we extracted β-21 
values using the MarsBaR toolbox (http://marsbar.sourceforge.net/) at a threshold of p<0.001 22 
(uncorrected; to account for greater anatomical variability) and subjected those to further 23 
testing using SPSS statistical software version 21.0 (SPSS, Chicago, Illinois). The associations 24 
with the physiological and psychometric parameters BMI-standard deviation score (BMI-25 
SDS)46, EDI-2, BDI-II and the anxiety subscale of SCL-90-R were examined using Pearson’s 26 
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r for each diagnostic group separately. Additionally, an analysis of the association with the 1 
core-scales of the EDI-2 (, drive for thinness and body dissatisfaction) is included in SM 2.4 2 
 3 
In order to probe the proposed serotonin-related epigenetic-brain-behavior pathway, we 4 
conducted a mediation analysis using PROCESS package implemented in SPSS. To this end, 5 
we tested whether the link between alterations in SLC6A4 methylationmean and elevated 6 
psychopathology (EDI-2 total, BDI-II and SCL-90-R anxiety ) is mediated by altered rsFC in 7 
the SN (indirect effect) in AN participants using the bootstrapping procedure on 20000 samples 8 
to compute the lower and upper level of the 95% confidence interval. 9 
Results 10 
Participants 11 
As shown in Table 1, there were no significant group differences in age. As expected, AN 12 
patients had a lower BMI-SDS as well as a higher EDI-2 total score, BDI-II score and SCL-90-13 
R anxiety level than HC. AN patients did not differ from HC in SLC6A4 methylationmean or 14 
methylationCpG13 (Table 1). SLC6A4 methylationmean was significantly associated with age 15 
(rp=0.22; p=0.021), thus we included age as a covariate in our main statistical models. 16 
Moreover, we investigated whether SLC6A4 methylationCpG13 is dependent on genetic 17 
variation. Based on publically available data, we could not identify underlying methylation 18 
quantitative trait loci in blood (mqtldb.org) or human brain tissue 19 
(epigenetics.essex.ac.uk.mQTL; SM 2.6).  20 
 21 
Group comparison of independent components and association with methylation 22 
A two-sample t-test of the two SN components (IC 13 and IC9) revealed increased rsFC within 23 
the left (t=4.68; p=0.006; k=15 (FWE)) and right (t=4.88; p=0.014; k=7 (FWE)) posterior insula 24 
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and IC9 for AN in comparison to HC (step 1; Figure 1). No group difference was identified for 1 
IC13. In step 2, we identified a group × methylationmean interaction in the right dorsolateral 2 
prefrontal cortex (dlPFC) for IC9, controlling for age (t=4.49; p=0.016; k=6 [32; 40; 34] (FWE); 3 
Figure 2, panel A). Detailed analysis of this interaction revealed that SLC6A4 methylationmean 4 
correlated positively with rsFC between this region and other areas of IC9 in AN patients 5 
(r=0.425; p=0.002), while this correlation was negative in HC (r=-0.408; p=0.002) (Figure 2, 6 
panel B). In step 3, we tested specifically the group × methylationCpG13 interaction and observed 7 
an identical neural pattern in the right dlPFC (t=4.73; p=0.018; k=5 [34; 38; 30] (FWE), see SM 8 
2.1).  9 
Control analysis in the visual network revealed no group x methylationmean interaction, 10 
suggesting that the finding described above was specific to the SN (step 4). Exclusion of 11 
participants with current or past cigarette consumption confirmed our initial results in the SN 12 
(t=5.09; p=0.007; k=13 [30; 40; 32] (FWE)). Excluding the participant who took SSRI also had 13 
no influence on the results (t=4.46; p=0.018; k=5 [32, 40; 34] (FWE)).  14 
Moreover, increased rsFC between the significant cluster in the dlPFC, for which we reported 15 
the group × methylationmean interaction, and other regions of the SN was associated with ED 16 
psychopathology, indicated by a correlation with the EDI-2 total score, but not with BMI-SDS, 17 
BDI-II or SCL-90-R anxiety, within the patient group (rp=0.349; p=0.010; withstands Bonferroni-18 
correction for four tests). Mediation analysis showed that the effect of SCL6A4 methylationmean 19 
on EDI-2 total, but not on BDI-II or on SCL-90-R anxiety, was  mediated by alterations in rsFC 20 
of the SN in AN participants (see Table 2 and SM 2.5).  21 
Discussion 22 
The present study is the first to investigate a potential epigenetic-brain-behavior pathway in 23 
AN by examining the association of SLC6A4 methylation and resting state rsFC of the SN in 24 
patients acutely ill with this disorder and HC. On a group level, we observed increased rsFC in 25 
the SN at the posterior insula in patients compared to controls, but – in agreement with 26 
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previous reports18,47 – no difference in SLC6A4 methylation levels. However, we did identify a 1 
positive association between methylation levels and rsFC between the dlPFC and other 2 
regions of the SN in AN participants, which was also associated with elevated ED symptoms. 3 
In fact, alterations in SN rsFC were found to mediate the link between SLC6A4 methylation 4 
changes and ED but not depressive or anxiety-related psychopathology. These results may 5 
suggest that this methylation-related rsFC pattern is specific for ED symptoms. However, to 6 
confirm this notion further research including other clinical groups is needed. In HC, increased 7 
SLC6A4 methylation levels were associated with reduced rsFC in this brain region. 8 
Importantly, these associations could be demonstrated for mean methylation levels as well as 9 
for CpG-specific methylation (SLC6A4 methylationCpG13) at a locus with previous evidence for 10 
a correspondence of methylation levels across blood and brain tissue16. Of note, no association 11 
between methylation and rsFC was detected in an a priori chosen negative control network – 12 
the visual network, indicating that the found association may be specific for the SN.  13 
Alterations in the SN have been described to underlie abnormal sensitivity to salient external 14 
or internal events with severe consequences for cognition and behavior, as described across 15 
several mental disorders48 including AN26. The posterior insula, the location of the general 16 
group difference in the SN, has been associated with pain and sensorimotor representation 17 
and is thought to function as a major interoceptive region49. In line with this, we have previously 18 
demonstrated altered functional network characteristics in the posterior insula in AN50,51, which 19 
may reflect inefficient information transfer to and from this brain region. Functional alterations 20 
in the posterior insula have also repeatedly been shown in AN using task-based fMRI52. Taken 21 
together, dysfunctions in the insular cortices relate to impaired integration of visuospatial, 22 
homeostatic and interoceptive signals, which may account for some of symptoms in AN, such 23 
as body image distortions, elevated pain threshold and severe self-starvation53.  24 
Our finding of methylation-related SN rsFC alterations, which was also associated with ED 25 
severity in AN, fits well with a previously reported notion of a clinically relevant brain-mediated 26 
association between SLC6A4 methylation and illness-related behavior28,30,54,55. In detail, 27 
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previous neuroimaging studies in health and disease (for review see Palma-Gudiel & 1 
Fañanás17) − as well as the here reported findings in AN − suggest that increased SLC6A4 2 
methylation may link to heightened activity and connectivity in SN-related brain regions in 3 
individuals with severe mental health conditions. In contrast to AN, we observed a negative 4 
(rather than positive) association between SLC6A4 methylation and rsFC in the SN in HC. 5 
Similarly, Frodl et al.29 demonstrated a negative association between methylation and neural 6 
reactivity in the posterior insula, pons and temporal pole when shifting attention away from 7 
emotional stimuli in a sample including HC and patients with major depressive disorder. In 8 
sum, the direction and exact localization of the association between SLC6A4 methylation and 9 
brain functioning is still somewhat unclear and difficult to compare due to different employed 10 
fMRI methods (resting state [seed-based30 versus ICA approach) or task fMRI] and contrast 11 
conditions in task fMRI.  12 
Interestingly, while previous studies investigating SLC6A4 methylation-related brain regions 13 
focused primarily on ventral-limbic parts of the brain such as the amygdala, we found a 14 
methylation-related increase in rsFC between the dlPFC and other regions of the SN in AN. In 15 
order to further probe the specificity of this finding regarding the SN, we also tested the fronto-16 
parietal network (network with the dlPFC as a central hub) as part of an additional follow-up 17 
analysis (SM 2.3). Similar to the visual network (negative control network), we could not detect 18 
a significant association between methylation and rsFC of the fronto-parietal network. Given 19 
that the methylation-related increase of rsFC was present in a section of the dlPFC belonging 20 
to the SN, but not for subregions of the dlPFC, which are part of the fronto-parietal network, 21 
we suggest that the associations with SLC6A4 methylation may be specific to the fronto-limbic 22 
circuit. This circuit is a component of the SN and part of the serotonin pathway, i.e. it is strongly 23 
innervated by serotonergic neurons and rich in various serotonin receptors56. With regard to 24 
processing emotions and saliency – a major function of the SN – the dlPFC (and its coupling 25 
with limbic regions) is also engaged during bottom-up appraisal of emotions57 and during 26 
emotion regulation via cognitive strategies58. Modulation of frontal-limbic circuits via the 27 
serotonergic system has previously been shown by studies focusing on the 5-HTTLPR. This 28 
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polymorphism is thought to modulate the association between lateral prefrontal cortex 1 
structure59 and biased attention to emotional stimuli60. Moreover, 5-HTTLPR was observed to 2 
be linked to cognitive symptoms present in mental disorder such as obsessive-compulsive 3 
disorder61 and AN62. Based on this, a speculative interpretation of our findings could be that a 4 
methylation-related increased involvement of the dlPFC in the SN is related to elevated 5 
cognitive or self control – a much debated characteristic of AN2. This tentative interpretation of 6 
the findings dovetails with the notion of AN as a model-disorder of increased cognitive control, 7 
which may be particularly reflected in the tendency of patients to respond in a strategic rather 8 
than hedonic manner to salient stimuli63,64. Interestingly, in a recent study we discovered a 9 
sustained lateral prefrontal cortex responsivity in AN participants when food-related, social but 10 
also neutral stimuli were presented64. We speculated that this may reflect an inability of AN 11 
patients to disengage cognitive control. In light of this, the current findings of a SCL6A4-12 
associated increased rsFC between dlPFC and the rest of the SN – although correlational in 13 
nature - may be interpreted as a tendency of AN patients to ‘stay in control’, which could 14 
potentially be a neural downstream effect of elevated SLC6A4 methylation, leading to 15 
unwanted effects such as increased ED symptoms.  16 
Limitations 17 
The interpretation of the present study rests upon the following limitations. First, the cross-18 
sectional nature of the study does not allow determining a causal link between epigenetic 19 
variation, brain network characteristics and the emergence of ED symptoms or whether the 20 
observed alterations are an effect of undernutrition. In order to shed light on temporal 21 
relationships, longitudinal study designs are needed. Second, methylation measures were 22 
assessed in peripheral tissue, which cannot be generalized to neural tissue. However, previous 23 
work could demonstrate a substantial association between the methylation-level in blood and 24 
brain for SLC6A4 methylationCpG1316,65, for which we could confirm our initial findings. 25 
Furthermore, while methylation at this site was somewhat low , which could add noise due to 26 
technical variation, the methylation levels in our study are in line with previously reported 27 
Neural correlates of SLC6A4 methylation in anorexia nervosa 
 
15 
 
levels66. Third, the present study only focused on epigenetic variation but failed to incorporate 1 
genetic variability and other influencing factors such as stress and childhood adversity. While 2 
the contribution of both epigenetic and genetic factors might be relevant to predict the 3 
expression of SLC6A417, SLC6A4 methylationCpG13 does not seem to be under strong genetic 4 
control.  Fourth, rates of comorbidity were lower than previously reported 67 which could be 5 
due to the fact that no structured interview other than the SIAB-EX was used (see SM 1.1). 6 
In conclusion, our findings suggest, if replicated, that a serotonin-related epigenetic-brain-7 
behavior pathway is also relevant for AN. It sheds light on the neuro-biological process of how 8 
epigenetic variation of the SLC6A4 gene may associate with rsFC in the SN that is specifically 9 
linked to ED symptoms. Such knowledge may spur future research on the potential of 10 
epigenetic markers to assess  risk for disordered eating and pave the way for potential novel 11 
pharmacological and behavioral treatment strategies that modulate methylation levels of 12 
specific genes68,69.  13 
 14 
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Table 1: Demographic and clinical characteristics; If not otherwise indicated mean and 1 
standard deviations are reported; BMI-SDS=body mass index standard deviation score, EDI-2 
2=eating disorder inventory 2; BDI-II=Beck’s depression inventory 2; SCL-90-R=Symptom 3 
Checklist 90 Revised; AN=patients acutely ill with anorexia nervosa; HC=healthy controls. 4 
 5 
Table 2: Mediation analysis between SCL6A4 methylationmean and the outcome 6 
variables EDI-2 total and BDI-II with rsFC of the SN as mediator; LLCI=lower level of the 7 
confidence interval; ULCI=upper level of the confidence interval; EDI-2=eating disorder 8 
inventory 2; BDI-II=Beck’s depression inventory 2.  9 
 10 
Figure 1: Two-sample t-test of the salience network; A two-sample t-test within the IC9 11 
revealed an increased functional connectivity between the left (t=4.68; p=0.006 (FWE)) and 12 
right (t=4.88; p=0.014 (FWE)) posterior insula and the rest of the component for AN in 13 
comparison to HC. 14 
 15 
Figure 2: Group × SLC6A4 methylationmean interaction; A) Results of the group × SLC6A4 16 
methylationmean interaction analysis in the SN at the dorsolateral prefrontal cortex cluster 17 
(dlPFC) (for illustrative purposes shown at p<0.001, uncorrected). Applied SN mask 44 is 18 
depicted in transparent grey. Color bar represents t-values. B) Plot of association of the 19 
extracted β-values of the dlPFC cluster and mean SLC6A4 methylation (in %) separately for 20 
AN and HC. AN=patients acutely ill with anorexia nervosa; HC=healthy controls. 21 
 22 
